Chunying Y. Li
No. 127 Of West Changle Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 159 publications
International expert consensus on transdermal drug delivery technologies in dermatology.
Journal: JAAD international
Published: April 30, 2026
Sympathetic nerve aggravates autoimmune skin disease via NE-adrenergic receptor axis: Neuroimmune cross-talk insights from vitiligo.
Journal: Science advances
Published: March 04, 2026
Refractory Dermatophytosis Caused by Trichophyton indotineae: A Case Series Highlighting Antifungal Resistance and Management Challenges.
Journal: Mycopathologia
Published: January 30, 2026
Real-world pharmacovigilance analysis and mechanistic exploration of JAK inhibitor-associated skin tumor adverse events using FAERS, VigiBase, and network pharmacology.
Journal: Journal of the American Academy of Dermatology
Published: January 21, 2026
Comparison of clinical features and disease-related factors in vitiligo patients between 2001-2011 and 2022-2024
Journal: Zhonghua yi xue za zhi
Published: December 16, 2025
Correction: A20 promotes melanoma progression via the activation of Akt pathway.
Journal: Cell death & disease
Published: November 20, 2025
Metabolic traits of T cells and the implications in autoimmune diseases.
Journal: Autoimmunity reviews
Published: October 06, 2025
Predicting sentinel lymph node metastasis in melanoma patients: A machine learning-based predictive model.
Journal: JAAD international
Published: September 30, 2025
GPNMB Drives Brain Metastasis by Sculpting a Pathologic Endothelial-Immune Interactome.
Journal: Cancer discovery
Published: September 23, 2025
Hyperglycemia aggravates vitiligo through succinate/SUCNR1-mediated T cell activation.
Journal: The Journal of clinical investigation
Published: September 16, 2025
Synergistic SHH activation and BMP inhibition remodel progenitor niche for enhanced hair cell generation.
Journal: Science China. Life sciences
Published: July 24, 2025
GSDME acts as an epigenetic modifier to promote melanoma development via centriole biogenesis regulator PLK4.
Journal: Cell death and differentiation
Published: July 08, 2025
Last Updated: 09/26/2026